Veeda Clinical Research IPO Upcoming
Already have an account? Apply now
About Veeda Clinical Research
Veeda Clinical Research Limited is a contract research organization (CRO) founded in 2004. Headquartered in India, Veeda offers a full spectrum of drug development services ranging from pre-clinical to Phase IV clinical trials. Veeda operates multiple state-of-the-art facilities and has a strong track record of regulatory compliance, supporting pharmaceutical and biotech clients worldwide.
Financials of Veeda Clinical Research
*All figures are in ₹ Crores.
Issue size
| Funds Raised in the IPO | Amount |
| Fresh issue | 185 |
| Offer for sale | Up to 13,008,128 Equity Shares |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Capital expenditure | 50 |
| Capital expenditure of subsidiary | 35 |
| Repayment/pre-payment, in full or in part of outstanding borrowings for subsidiary | 10.8 |
| Funding organic growth of Company | 33 |
| General corporate purposes | The amount utilised for general corporate purposes shall not exceed 25% of the Gross Proceeds |
Strengths
- Comprehensive CRO platform spanning the entire drug development cycle.
- Strong global infrastructure with regulatory-compliant research facilities.
- Proven success in strategic acquisitions and service integration.
- Deep scientific expertise across therapeutic areas and modalities.
- Global leadership team driving innovation and operational excellence.
Risks
- Non-compliance with regulations may impact operations and reputation.
- Revenue depends heavily on a few large clients.
- Delays in trials can affect financial performance significantly.
- Data breaches may expose confidential sponsor and patient data.
-
Subject to ongoing and potential future legal proceedings.